![\"Novo](\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/05\/1778889083_582_cf55459c3d728f46af023ee4ab7894c8.jpeg\")
<\/a> Novo Nordisk Canada Inc (CNW Group\/Novo Nordisk Canada Inc.) <\/p>\nNovo Nordisk Care\u00ae\u00a0Rx is a one-stop solution, that safely dispenses and ships medications \u2013 with the support of Rexall’s online pharmacy, Rexall Direct \u2013 right to Canadians’ homes at no additional cost, reducing the need for in-person pharmacy visits while helping ensure timely, secure access to treatment. Patients will have the opportunity to chat with a Rexall pharmacist over the phone and receive personalized education, advice, and ongoing support.<\/p>\n
“For more than a century, Novo Nordisk has supported people living with chronic conditions. As Canadians look for simpler, more convenient ways to manage their health in everyday life, this partnership with Rexall Direct helps make trusted treatments for type 2 diabetes and obesity easier to access\u2014delivered directly to people’s homes with discretion and care,” said Iain Graham, General Manager of Novo Nordisk Canada.<\/p>\n
“At Rexall, our focus is on making care more accessible, convenient, and patient\u2011centered. Our partnership with Novo Nordisk represents another meaningful step in delivering on that commitment. Through this collaboration, customers can confidently access Ozempic\u00ae and Wegovy\u00ae products from a trusted pharmacy, receive personalized support and guidance from our pharmacists, and manage their care from the comfort of their own home. Together, we share a belief that better health outcomes begin by removing barriers to care and supporting the overall health and well\u2011being of people across Canada,” said Jeff Boutilier, Chief Operating Officer, Rexall Pharmacy.<\/p>\n
Research shows that many people living with type 2 diabetes manage multiple medications alongside other chronic conditions, adding complexity to everyday life.1\u00a0Novo Nordisk Care\u00ae\u00a0Rx was designed with this in mind; providing reliable access to all of their prescriptions through a single, convenient service could help reduce the day\u2011to\u2011day burden and support people in staying on track with their care. People living with obesity frequently encounter barriers in the healthcare system, including experiences of weight bias and stigma that can limit access to appropriate care.2\u00a0Solutions that make it easier to access prescribed care\u2014such as home delivery\u2014may help remove some of those barriers and better support individuals on their health journey.<\/p>\n
About Novo Nordisk Care\u00ae Rx
Novo Nordisk Care\u00ae\u00a0Rx is a service designed to support patients who have been prescribed select Novo Nordisk medications by offering home delivery through Rexall Direct. Savings are automatically applied for eligible patients and there is no subscription fee. The platform offers convenient and fast delivery, meeting Canadians where they are. The platform offers continuous support for patients through both Novo\u00a0Nordisk Care\u00ae and Rexall Direct.<\/p>\n
The service has launched across all Canadian provinces and territories \u2013 except Quebec \u2013 providing millions of Canadians with convenience, support, and a modern approach to prescription management. For more information on Novo Nordisk Care\u00ae Rx, Canadians can visit www.NovoNordiskCareRx.ca<\/a>.<\/p>\n About Novo Nordisk About Rexall *Available in all provinces and territories except Quebec.<\/p>\n ____________<\/p>\n 1\u00a0Vallis M, Jin S, Klimek-Abercrombie A, Ng G, Ivers NM. A Qualitative Study of Barriers to Medication-Taking Among People With Type 2 Diabetes Using the Theoretical Domains Framework. Diabetes Spectr. 2024 Mar 5;37(3):264-272. doi: 10.2337\/ds23-0038.\u00a0<\/p>\n 2\u00a0Gupta N, Bombak A, Foroughi I, Riediger N. Discrimination in the health care system among higher-weight adults: evidence from a Canadian national cross-sectional survey. Health Promot Chronic Dis Prev Can. 2020 Nov\/Dec;40(11-12):329-335. doi: 10.24095\/hpcdp.40.11\/12.01.<\/p>\n View original content to download multimedia: http:\/\/www.newswire.ca\/en\/releases\/archive\/May2026\/13\/c6277.html<\/a><\/p>\n
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 76,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.ca<\/a>, Facebook<\/a>, Instagram<\/a>, X<\/a>, LinkedIn<\/a> and YouTube<\/a>.<\/p>\n
Rexall is a leading pharmacy retailer in Canada, dedicated to caring for Canada’s health, one person at a time. Through Rexall Direct, the company offers convenient prescription delivery and virtual pharmacy support to patients across Canada.* For more information, visit rexall.ca or rexalldirect.ca.<\/p>\n Cision <\/p>\n